Data-driven stock analysis, valuation deep dives, and financial forensics. Every article backed by the numbers.
The dividend headlines treat KO as a slow-growth defensive. The 38% jump in operating income, the Marriott commercial win, and the fairlife capacity expansion tell a different story.
The 70th consecutive annual raise reads as a cliche. The capital allocation math behind it does not. PG has returned more than $110 billion to shareholders over the last decade while growing per-share free cash flow faster than the headline revenue growth rate suggests.
RTX's order backlog has outpaced revenue by a wide margin for three years running. At 29x forward earnings, the multiple reflects that gap closing, not the gap widening further. The $12 billion Germany naval deal is the latest proof the gap is still widening.
The European Commission's green light for clesrovimab opens the RSV infant prevention market to Merck's monoclonal antibody. For a stock priced on the Keytruda loss-of-exclusivity cliff, this is the first material piece of evidence that the pipeline can backfill the gap.
At 41x forward earnings the multiple looks demanding. The order book and HighNA mix shift make 41x look like the floor, not the ceiling, of where this stock should trade.
The Q1 MedTech data is the line item the market was not pricing. Combined with a Stelara erosion curve that is shallower than the 2024 bear case assumed, the forward-earnings arithmetic changes.
The 2026 Medicare Advantage rate letter does more than stabilise the utilisation shock. At 18x forward earnings, the stock is still priced for permanent margin impairment. The math says otherwise.
Alphabet spent $91 billion on capex in 2025. Meta spent $70 billion. Both blamed AI infrastructure. One is showing clearer returns on the spend than the other, and the market has not fully separated them yet.
Snowflake, Datadog, and Cloudflare sit at the centre of the broadening software rally identified on 17 April. Each has a distinct setup, but the common thread is a free cash flow inflection that consensus has only partially recognised.
FCX has lifted from $32 at the 52-week low to $67 today, a 110% move, as the copper supply deficit narrative accelerated. Free cash flow compressed from $2.35 billion to $1.12 billion in the same window. The thesis update is more nuanced than the price chart suggests.
Honeywell announced a plan in early 2025 to split into three independent companies: Aerospace, Automation, and Advanced Materials. The split is structural; the implied sum-of-the-parts valuation is roughly 15-20% above the current enterprise value.
The consensus frames AbbVie as a post-Humira recovery story with a 14x forward P/E and a 3.2% dividend. The debt stack, the net income trajectory, and the biosimilar trajectory tell a more cautious story.
A report this week that Rivian is pitching major carmakers on software platform deals reframes the company from vertically integrated EV maker to software licensor. The Volkswagen joint venture was the template; the next deal could be the inflection.
Free cash flow has moved from negative to $324 million in three years. Workers AI has become the reference compute layer for inference at the edge. The April 17 rally hinted at what the data has been saying for twelve months.
The consensus view is that Disney is a legacy media business stuck between a declining linear network cash cow and a structurally unprofitable streaming unit. Free cash flow of $10.1 billion, up from $4.9 billion two years ago, says the consensus is looking at old data.